Because the overexpression of MIAT was significantly associated with progression in NSCLC patients, we further modulated MIAT expression to examine whether MIAT regulated the proliferation of A549 and H1299 cells. The gene discussed is MIAT; the disease is non-small cell lung carcinoma.